CSL Seqirus
UK - MaidenheadBiotechnology
Focus: CSL Seqirus is a UK-based biotechnology company specializing in vaccines and infectious disease treatments, with a diversified pipeline spanning immunoglobulins, coagulation factors, and gene therapies. The company operates as part of the CSL Limited group and maintains a significant commercial and R&D footprint.
Profile data last refreshed 5h ago · AI intelligence enriched 2w ago
Open Jobs
189+8 this month
Growing — net +8 jobs in 30d
114 jobs added vs 106 removed. Steady team buildout.
Should You Work at CSL Seqirus?
AI assessmentCSL Seqirus offers stable career growth in specialty pharma with particular appeal for Commercial and Regulatory professionals, but limited financial transparency creates uncertainty about long-term security.
Why Work Here
- Broad therapeutic portfolio across vaccines, immunology, and rare blood disorders offers exposure to multiple disease areas and development stages
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
50 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Help build intelligence for CSL Seqirus
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.